Deven Shah

Title: Deven Shah: Innovator in Pharmaceutical Chemistry

Introduction

Deven Shah is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on polymorphic forms of chemical compounds. With a total of 2 patents, his research has the potential to impact drug formulation and delivery.

Latest Patents

One of Deven Shah's latest patents involves the polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide. This patent discloses novel polymorphic trihydrated forms of this compound, characterized by a specific X-ray powder diffraction pattern. The crystalline form, referred to as 'Compound A crystalline trihydrate form I', is defined by its unique diffraction angles when measured using Cu Ka radiation.

Career Highlights

Deven Shah is currently employed at Chemocentryx, Inc., where he continues to advance his research in pharmaceutical innovations. His work is crucial in developing new therapeutic options and improving existing formulations.

Collaborations

Throughout his career, Deven has collaborated with esteemed colleagues, including David H Igo and Bert Ho. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Deven Shah's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in drug formulation and delivery systems.